Clinical Trial Update: A Phase I Clinical Trial to Evaluate CMS-D017 Following Single and Multiple Doses in Healthy Participants [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update evaluating CMS-D017 after single and multiple doses in healthy participants, and the study is currently recruiting. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complement-mediated Kidney Disease
• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• CMS-D017 (CMS-D017)

Snippet

Sponsor: Shenzhen Kangzhe Biotechnology Co., Ltd. | Conditions: Paroxysmal Nocturnal Hemoglobinuria, PNH, Complement-mediated Kidney Disease | Phase 1 | Status: RECRUITING